Additional anti inflammatory therapies have been reported which decrease diabetes-induced retinal leukostasis and permeability or retinal ICAM1 such as corticosteroids[18], RAGE inhibitors [19], and salicylates [20]. Here, ICAM1 is linked to diabetes mellitus.